phone call +1 347 964 0123

phone +39 06 9934 1213

email  This email address is being protected from spambots. You need JavaScript enabled to view it.


Russian Version



Logo MTI1



Synchrotron and hadrontherapy are ideally suited to treat tumours that are deep-seated, located close to critical organs and respond poorly to conventional photon or electron radiotherapy.

  • cancer of the prostate and rectum (pelvic district)
  • pancreatic cancer
  • melanoma of the rectum and vagina
  • abdominal area - cancer of the liver and bile
  • brain cancer
  • cranial base cancer
  • central nervous system
  • lung cancer
  • tumors of epithelial origin
  • eyeball and eye socket
  • head and neck
  • paranasal sinuses and nasal cavities
  • salivary glands
  • bone and soft tissue

video icon


Synchrotron structure

Synchrotron area

Synchrotron room

Synchrotron scheme


CNAO’s ‘High Technology’ components consist of a set of accelerators and transport lines of particle beams. The beams are generated by sources that produce carbon ions and protons. The most important accelerator machine is the Synchrotron. The synchrotron at CNAO is a prototype resulting from the research in high energy physics made possible through the collaboration of the Istituto Nazionale di Fisica Nucleare (INFN), CERN (Switzerland), GSI (Germany), LPSC (France) and of the University of Pavia University (Italy). It is based mostly on Italian technology.

The particle beam is accelerated in the synchrotron and travels about 30,000 kilometers in a half second to reach the desired energy. The beams are then sent to one of the three treatment rooms. Above this station there is a magnet of 150 tons which bends 90 degrees the particle beam and directs it from above to the person to be healed.

read more ...




cnao CNAO

The National Centre of Oncology (CNAO) was created with the goal of treating tumors by using protons and carbon ion particles belonging to the category of hadrons.

The CNAO Foundation is also a Centre of Research and Development, whose activities range from clinical and radiobiological research to translational research with the objective of providing continual improvements in the capacity to cure.

Following-up all the patients after hadron-therapy in the Centre and in all the hadron-therapy Centres around the world, the effectiveness of the therapy will be established. This knowledge will affect therapy protocols, with by-products on Centre technologies.

The prices, extremely low in Italy, depending on the treatment.